OFIX
Orthofix Medical Inc.NASDAQHealthcare$11.53-0.69%ClosedMarket Cap: $462.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.02
P/S
0.56
EV/EBITDA
7.24
DCF Value
$-91.09
FCF Yield
-0.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.1%
Operating Margin
-8.3%
Net Margin
-11.2%
ROE
-20.4%
ROA
-15.8%
ROIC
-10.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $219.9M | 64.6% | $13.5M | $-2.2M | $-0.06 | — |
| FY 2025 | $822.3M | 67.1% | $-68.5M | $-92.2M | $-2.28 | — |
| Q3 2025 | $205.6M | 72.2% | $-17.0M | $-22.8M | $-0.57 | — |
| Q2 2025 | $203.1M | 68.7% | $-16.0M | $-14.1M | $-0.36 | — |
| Q1 2025 | $193.6M | 62.8% | $-48.9M | $-53.1M | $-1.35 | — |
| Q4 2024 | $215.7M | 69.0% | $-11.5M | $-29.1M | $-0.75 | — |
| FY 2024 | $799.5M | 68.3% | $-84.6M | $-126.0M | $-3.30 | — |
| Q3 2024 | $196.6M | 68.7% | $-18.9M | $-27.4M | $-0.71 | — |
| Q2 2024 | $198.6M | 67.8% | $-24.9M | $-33.4M | $-0.88 | — |
| Q1 2024 | $188.6M | 67.5% | $-29.3M | $-36.0M | $-0.95 | — |
| Q4 2023 | $200.4M | 68.2% | $-18.3M | $-22.2M | $-0.60 | — |
| FY 2023 | $746.6M | 65.1% | $-139.1M | $-151.4M | $-4.12 | — |